Open original FDA record ↗Recall record
- FDA identifier
- Z-0029-2013
- Company in FDA record
- Alere San Diego, Inc.
- FDA classification date
- Oct 10, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Biosite is recalling the Triage TOX Drug Screen kits where the box containing test devices because it was mislabeled.
Source facts
- Action
- Biosite sent a Notice of Correction letter dated May 28, 2009 to all their customers who purchased the Triage TOX Drug Screen. The letter informed the customers of the problem identified and actions to be taken. Customers are instructed that performance of Triage TOX Drug Screen test devices is not affected in any way by the misprinted box flap, provided the test is used with a urine sample as per the instructions for use. Customers are instructed to complete and fax the enclosed verification form within 10 days. In the US, customers were instructed to contact Biosite at (877) 441-7440 or email productadvisory@invmed.com. Customers in UK are instructed to contact European Representative, Lesley Paice, lesley.paice@invmed.com.
- Initiated
- 2009-05-28
- Root cause
- Error in labeling
- Terminated
- 2012-10-10
- Distribution
- Worldwide Distribution - US Nationwide and the countries of Australia, Belgium, Brazil, Canada, Colombia, Czech Republic, Finlind, France, Germany, Great Britian, Greece, Guatemala, Hong Kong, India, Indonesia, Italy, Lebanon, Mexico, Netherlands, Norway, Puerto Rico, Romania, Saudi Arabia, South Africa, South Korea, Spain, Switzerland, Taiwan, Tunisia, Turkey, United Arab Emirates, and Uruguay.
- Recall number
- Z-0029-2013
- Recall status
- Terminated
- CDRH record ID
- 112805
- FDA classified
- 2012-10-10
- Recall event number
- 63175